Studies on the effects of glucosamine on human prostate carcinoma DU145 cells in vitro identified several molecular events in its anti-tumor activity: up-regulation of CDK inhibitor p21waf1/cip expression, down-regulation of apoptosis inhibitor survivin and the most important suppression of STAT3 signaling pathway. This evidence concerns the gene STAT3 and neoplasm.